Huang W, Han X, Zhou J, Zhang G
Medicine (Baltimore). 2025; 104(7):e41557.
PMID: 39960926
PMC: 11835118.
DOI: 10.1097/MD.0000000000041557.
Ali S, Khan H, Malik A, Ali S, Hussain A
Cureus. 2025; 17(1):e77013.
PMID: 39912039
PMC: 11798423.
DOI: 10.7759/cureus.77013.
Faridzi A, Ariani Sugianto G, Gumilar K, Tjokroprawiro B
Am J Case Rep. 2025; 26():e945078.
PMID: 39819883
PMC: 11751734.
DOI: 10.12659/AJCR.945078.
He Q, Wang C, Huang D, Shen J, Liu R, Guan Y
Med Oncol. 2024; 42(1):2.
PMID: 39541042
DOI: 10.1007/s12032-024-02544-w.
Mulders M, Verschuur A, de Lussanet de la Sabloniere Q, Roes E, Geisenberger C, Brosens L
J Pathol Clin Res. 2024; 10(6):e70000.
PMID: 39513463
PMC: 11544441.
DOI: 10.1002/2056-4538.70000.
The evolving landscape of immunohistochemistry in cervical and uterine carcinoma in gynecologic oncology: current status and future directions.
Gupta S, Ahuja S, Kalwaniya D
Obstet Gynecol Sci. 2024; 67(5):449-466.
PMID: 39231489
PMC: 11424185.
DOI: 10.5468/ogs.24120.
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Bellone S, Jeong K, Halle M, Krakstad C, McNamara B, Greenman M
Proc Natl Acad Sci U S A. 2024; 121(17):e2321898121.
PMID: 38625939
PMC: 11046577.
DOI: 10.1073/pnas.2321898121.
Incidental Diagnosis of a Primary Pure "Mixed" Ovarian Carcinoid: Clinicopathological Report and Concise Review of the Recent Series.
Larrain D, Garate M, Diaz L, Rojas I
Case Rep Obstet Gynecol. 2024; 2024:5890300.
PMID: 38572183
PMC: 10990638.
DOI: 10.1155/2024/5890300.
Adenocarcinoma admixed with neuroendocrine carcinoma of the cervix: A case report and review of literature.
Molla Y, Alemu H, Selamawi A, Tesema A, Answar I, Tadesse A
Case Rep Womens Health. 2024; 41:e00594.
PMID: 38515997
PMC: 10955200.
DOI: 10.1016/j.crwh.2024.e00594.
Clinical analysis of 12 cases of ovarian neuroendocrine carcinoma.
Xing X, Zhang W, Liu L, Han L
World J Clin Cases. 2024; 12(6):1111-1119.
PMID: 38464918
PMC: 10921297.
DOI: 10.12998/wjcc.v12.i6.1111.
Combined Carcinoid Carcinoma and Squamous Cell Carcinoma of the Endometrium: A Case Report and Survey of Related Literature.
Han Y, Zhang Y, Niu L, Sang C
Case Rep Oncol. 2023; 16(1):1402-1408.
PMID: 38028571
PMC: 10651180.
DOI: 10.1159/000534622.
Application of preoperative fluorodeoxyglucose-PET/CT parameters for predicting prognosis of high-grade neuroendocrine cervical cancer.
Song C, Lee J, Lee S, Park J, Kim D, Suh D
Nucl Med Commun. 2023; 44(11):1005-1010.
PMID: 37578339
PMC: 10566590.
DOI: 10.1097/MNM.0000000000001741.
A Comprehensive Review on Neuroendocrine Neoplasms: Presentation, Pathophysiology and Management.
Sultana Q, Kar J, Verma A, Sanghvi S, Kaka N, Patel N
J Clin Med. 2023; 12(15).
PMID: 37568540
PMC: 10420169.
DOI: 10.3390/jcm12155138.
Fortuitously detected primary ovarian carcinoid tumor: A case report.
Choi H, Pak M, Park J
Medicine (Baltimore). 2023; 102(31):e34391.
PMID: 37543794
PMC: 10402998.
DOI: 10.1097/MD.0000000000034391.
Metastasis to Thyroid Gland from Neuroendocrine Carcinoma of Endometrium: A Rare Entity.
Ramchandrappa K, Shah R, Tyagi A
Indian J Otolaryngol Head Neck Surg. 2023; 75(2):1049-1051.
PMID: 37274955
PMC: 10235269.
DOI: 10.1007/s12070-022-03335-3.
Mixed mucinous adenocarcinoma/large cell neuroendocrine carcinoma of the uterine cervix: case report and molecular characterization of a rare entity.
Fattorini C, Rocca B, Giusti A, Arganini M, Perotti B, Cavazzana A
Virchows Arch. 2023; 484(1):141-146.
PMID: 36988712
PMC: 10052266.
DOI: 10.1007/s00428-023-03532-7.
A Nomogram Model Based on Neuroendocrine Markers for Predicting the Prognosis of Neuroendocrine Carcinoma of Cervix.
Jia M, Pi J, Zou J, Feng M, Chen H, Lin C
J Clin Med. 2023; 12(3).
PMID: 36769874
PMC: 9917535.
DOI: 10.3390/jcm12031227.
Mixed high-grade serous and large cell neuroendocrine carcinoma arising from rectal endometriosis 11 years after hysterectomy.
Yanagita T, Hikichi T, Waragai Y, Shimizu H, Takahashi Y, Abe N
Clin J Gastroenterol. 2023; 16(3):366-371.
PMID: 36763235
DOI: 10.1007/s12328-023-01769-y.
Positive clinical outcomes following therapy with programmed cell death protein 1/programmed cell death ligand 1 inhibitors in neuroendocrine carcinoma of the cervix.
Liu R, He X, Li Z
Front Pharmacol. 2022; 13:1029598.
PMID: 36467090
PMC: 9712751.
DOI: 10.3389/fphar.2022.1029598.
Paraganglioma of the Fallopian Tube Presenting as Isolated Fallopian Tube Torsion.
Takeda A, Watanabe K, Koike W, Tsuge S
Case Rep Oncol. 2022; 15(2):617-623.
PMID: 35949901
PMC: 9247534.
DOI: 10.1159/000525205.